Novel protocol for selection of SARS-CoV-2 convalescent plasma donors

Novel protocol for selection of SARS-CoV-2 convalescent plasma donors

Background/Aim. Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) 2019 infection represents a global problem. At this moment, in October 2020, there is no vaccine or efficient treatment for infected patients. Treatment with blood plasma rich with anti-SARS-CoV-2 specific antibodies might...

Full description

Bibliographic Details
Main Authors: Abazović, D. (Author), Gojkov, D. (Author), Karličić, M. (Author), Karličić, V. (Author), Kovačević, M. (Author), Ostojić, G. (Author), Ristanović, E. (Author), Stanojević, I. (Author), Šupić, G. (Author), Vojvodić, D. (Author), Vukosavljević, M. (Author)
Format: Article
Language:English
Published: Inst. Sci. inf., Univ. Defence in Belgrade 2022
Subjects:
antibody specificity
clinical protocols
covid-19 serotherapy
enzyme-linked immunosorbent assay
plasma
SARS-CoV-2
tissue donors
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items